Charles River Launches Novel IgY-based ELISA Kit for the Detection and Quantitation of Residual Host

HCP-ELISA builds upon Company’s HCP-GAPex℠ service, increasing the efficiency and efficacy of HCP assay developmentWILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #LIFEatCRL--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its first Enzyme-Linked Immunosorbent Assay (ELISA) Kit for...

Related Keywords

United States ,Todd Spencer ,Debra Tosto ,Kerstin Dolph ,Olaf Stamm ,Amy Cianciaruso ,Company Hcp Gapex ,Biologics Solutions ,Technical Business Development ,Senior Business Development Specialist ,Crl Lifeatcrl Charles River Laboratories International Inc ,Charles River Laboratories International ,Enzyme Linked Immunosorbent Assay ,Charles River ,Specific Pathogen Free Chicken ,Biologics Testing ,Technical Business Development Director ,Corporate Senior Vice President ,Vice President ,